Overexpression of matrix-metalloproteinase-9 in human breast cancer: A potential favourable indicator in node-negative patients

British Journal of Cancer

Volumn 84, Issue 11, 2001, Pages 1488-1496

  Scorilas, A ^a,b,c   Karameris, A ^b   Arnogiannaki, N ^a   Ardavanis, A ^a   Bassilopoulos, P ^a   Trangas, T ^a   Talieri, M ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Breast cancer; MMP 9; Prognostic factor

Indexed keywords

CATHEPSIN D; GELATINASE B;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODE EXCISION; MASTECTOMY; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT CARE PLANNING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035362633     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1810     Document Type: Article

References (57)

1. Cathepsin-D concentration in tumour cytosols improves the accuracy of prognostic evaluation of primary breast cancer
2. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
3. Roles of the matrix metalloproteinases in mammary gland development and cancer
4. Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer
5. Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development
6. Transforming growth factor-b mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium
7. Changing views of the role of matrix metalloproteinases in metastasis
8. Laminin receptors, collagenase IV and prognosis in node negative breast cancers
9. The urokinase receptor: Protein structure and the role in plasminogen activation and cancer invasion
10. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
11. Assay of matrix metalloproteinases types 8 and 9 by ELISA in human breast cancer
12. Immunochytochemical localization of progesterone receptors in breast cancer with antihuman receptor monoclonal antibodies
13. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
14. Proteolysis in human breast and colorectal cancer
15. MMP-9 activity in urine from patients with various tumors, as measured by a novel MMP activity assay modified urokinase as a substrate
16. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
17. Stromal cell expression of components of matrix degrading protease systems in human cancer
18. Anti-tumor promotion and anti-inflammation: Down-modulation of AP-1 (Fos/Jun) activity by glycocorticoid hormone
19. Expression of MMP-2 and MMP-9, their inhibitors and the activator MT1-MMP in primary breast carcinomas
20. Nonparametric estimation from incomplete observations
21. Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study
22. Improvements in steroid receptor assays including rapid computer analysis of data
23. Tumor invasion and metastasis: An imbalance of positive and negative regulation
24. Down-regulation of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) in malignant vs non-malignant prostatic tissue
25. Insulin-like growth factor-1 triggered cell migration and invasion are mediated by matrix metalloproteinase-9
26. Matrix metalloproteinase: Biologic activity and clinical implications
27. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer
28. Messenger RNA for urokinase plasminogen activator (uPA) is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
29. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer
30. Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: Clinico-pathological correlations
31. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells
32. Assay of matrix metalloproteinases types 1,2,3 and 9 in breast cancer
33. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression
34. Different expression patterns of MMP-2 and MMP-9 in breast cancer
35. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors are modulated by progesterone withdrawal in an in vitro model for menstruation
36. Cathepsin-D and c-erbB-2 have an additive prognostic value for breast cancer patients
37. c-erB-2 overexpression may be used as an independent prognostic factor for breast cancer patients
38. Predictive value of c-erbB-2 and Cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis
39. Determination of c-myc amplifications and overexpression in breast cancer patients. Evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathologic characteristics using univariate and multivariate analysis
40. Immuno-enzymatically determined pepsinogen C concentration in breast tumor cytosols: An independent favorable prognostic factor in node-positive patients
41. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer
42. Genomic organization, physical mapping and expression analysis of the human protein arginine methyltransferase 1 gene
43. Mechanisms of cell surface activation of 72-kDa type IV collagenase
44. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis
45. Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: A novel approach from immune/inflammatory aspect
46. Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal primary breast cancer
47. Type IV collagenase in invasive tumors
48. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence
49. Pepsinogen C is a new prognostic marker in primary breast cancer
50. Gelatinase B Structure, regulation and function
51. Cathepsin B and human tumor progression
52. Genomic organization, mapping, tissue expression and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family
53. The new human kallikrein gene KLK15 is up-regulated in prostate cancer
54. Prognostic value of prostate-specific antigen for women with breast cancer: A large United States cohort study
55. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invation
56. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues